The neuroprotective effects of PPARα have been confirmed in several disease models, such as stroke, traumatic brain injury, Parkinson’s disease, Alzheimer’s disease and diabetic peripheral neuropathy [23,24,25,26]. Here, PPARA is linked to early-onset autosomal dominant Alzheimer disease.